Analysis of the drug assortment for treating nicotine dependence presented at the pharmaceutical market of Ukraine
The analysis of the drug assortment for treating nicotine dependence presented at the Ukrainian pharmaceutical market has been carried out according to the ATC-classification and countriesproducers with the purpose of providing the population with effective, qualitative and safe medicines. Two types of therapy are used for nicotine addiction: nicotine replacement therapy and therapy with the use of medicines, which do not contain nicotine. In the process of our investigations it has been found that 11 trade names (TD) of medicines for treating nicotine dependence (MTND) have been registered in Ukraine. Among them there are 8 nicotine-containing drugs, 1 medicine contains cytisine, 1 includes varenicline and 1 is a homeopathic medicine produced by 5 countries. It has been determined that the majority of medicines for treating nicotine dependence are presented by foreign producers at the Ukrainian market. The majority of the drug assortment for treating nicotine dependence is imported drugs of such pharmaceutical companies as McNeil, AB (Sweden); Novartis Consumer Health, S.A. (Switzerland); Sopharma (Bulgaria), Pfizer (the USA). The analysis of medicines for treating nicotine dependence has been carried out by medicinal forms. Medicines for treating nicotine dependence are presented at the market of Ukraine in such forms as chewing gums, tablets, transdermal plasters, granules. According to the maximum indexes received the assortment contour of the target segment of the Ukrainian pharmaceutical market of MTND (macrocontour) has been developed. The macrocontour of the target market segment can be used for studying the assortment of a particular chemist’s shop with the purpose of possibility of the assortment extension.
Dremova N.B., Ovod A.I. // Kursk scientific and practical reporter “Man and its health”. – 2006. – №3. – P. 41-54.
Golichenko M. Canadian HIV/AIDS Legal Network. – 2011. – P. 8-13.
Holtfreter B. // J. of Clin. Periodontol. – 2010. – Vol. 37. – Р. 211-219.
Kolassa E. // J. of Pharmac. Markеting and Management. – 2002. – Vol. 14, №3-4. – P. 101-108.
Malhotra S. // J. of Pharmac. Marketing and Management. – 2004. – Vol. 16, №4. – P. 97-106.
Martsevich S.U., Lukina U.V. // [Electronic resource]: – Режим доступа: http://elibrary.ru/item.asp?id=18747155
Mnushko Z.N., Pestun I.V. Theory and practice of marketing investigations in pharmacy. – Kharkov: publ. NPhaU, 2008. – P. 15-22.
Niklaus P. Lang // J. of Clin. Periodontol. – 2009. – Vol. 36. – Р. 3-8.
Philip M. Preshaw // J. of Clin. Periodontol. – 2009. – Vol. 36. – Р. 1-2.
Rx-index. Classifier of medical preparations.[Electronic resource]: – Regime of access :http://www.rxindex. com.ua/atc#N07BA
Smirnov V.K., Ermolova O.I., Speranskaya O.I. // Narcol. – 2010. – №6. – P. 36-39.
State register of medicines [Electronic resource]: – Regime of access: http://www.drlz.Kiev.ua/
Tonnesen P. // JAMA. – 2003. – Vol. 269. – P. 1268-1271.
Velitchka D., Weitz B. // J. of Marketing. – 2006. – Vol. 70, №1. – P. 48-56.
Ziryanov S.K., Belousov U.B. // Preventive Medicine. – 2010. – Vol. 13, №6. – P. 21-23.
GOST Style Citations
This work is licensed under a Creative Commons Attribution 4.0 International License.
Abbreviated key title: News of pharm.
ISSN 2415-8844 (Online)